APPLICATION
NDA220050
TYPE
NDA
ORIGINAL APPROVAL
2024-11-09
LATEST ACTION
2024-11-09
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
GAS
MARKETING STATUS
Prescription
Products
Carbon Dioxide, USPPrescription
Carbon Dioxide, USP N/A · GAS · INHALATION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.